Press Releases

James Sailer Named Executive Director of Population Council’s Center for Biomedical Research

NEW YORK, NEW YORK (September 14, 2016) — The Population Council announced that James Sailer, a Council Vice President, has been appointed Executive Director of its Center for Biomedical Research (CBR), a renowned institution that conducts basic and clinical research and develops sexual and reproductive health products for women and men.  

For 60 years, the Council’s Center for Biomedical Research has been at the forefront of efforts to understand, develop, and introduce a range of products and strategies to protect women, men and young people’s sexual and reproductive health.  More than 170 million women worldwide are using a highly effective contraceptive developed by the Population Council or based on the Council’s technologies, including the intrauterine products, ParaGard® and Mirena®, the implants Norplant® and Jadelle®, and Progering®, a contraceptive vaginal ring suitable for breastfeeding women.  And today researchers are pioneering bold approaches to reducing sexually transmitted infections (STIs), including HIV, and unintended pregnancy by developing a new generation of products, called multi-purpose prevention technologies (MPTs). 

Considerable strides have been made to provide access to contraceptives and reduce the devastating global impact of STIs.  However, more than 225 million women in developing countries who want to prevent pregnancy are not using modern forms of contraception.  And more than one million people are becoming infected with a sexually transmitted infection every day. 

“This is an opportune moment for CBR – we have an all-star team of scientists developing and testing products designed to address multiple sexual and reproductive health needs,” said Julia Bunting, president of the Population Council.  “Jim is a skilled strategist who understands the product development landscape.  Under his leadership, CBR will continue to deliver products that meet the real-world prevention needs of men and women and ultimately, improve global health.”

Sailer has been actively involved in the Council’s biomedical product portfolio through his role as Vice President of Corporate Affairs, in which he has negotiated license agreements and managed business relationships with the Population Council’s pharmaceutical and development partners.   He oversees the Population Council’s submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for a novel one-year investigational contraceptive ring.  If approved by regulatory authorities, the ring would be the first long-acting form of contraceptive entirely under a woman’s control to use.  

Sailer brings to CBR in-depth expertise and broad perspective from his leadership in the nonprofit, government, and private sector.  He has overseen the Council’s partnerships with pharmaceutical companies to dramatically expand access to Council-developed contraceptives and other products to the global market.  In keeping with the Council’s mission, these partnerships include provisions to ensure that products are offered to people in less-developed countries at public-sector prices.

For more than a decade, Sailer served as the Population Council’s vice president of Corporate Affairs, leading operations, communications, publishing, human resources, information technology, and administration.  Before joining the Council, Sailer was director of performance management for the New York City Department of Education, where he developed an accountability system and sophisticated new methods of analyzing school performance.  He is the chairman of the board of InsideNGO, a membership association of more than 350 international non-governmental organizations (NGO) dedicated to improving the operational and management capacity of organizations in the global NGO community.  He is also a member of the board and executive committee of the International Contraceptive Access (ICA) Foundation and is a member of the Licensing Executives Society.

“I am honored to have the opportunity to be leading one of the single most effective nonprofit product development entities ever created,” said Jim Sailer, executive director.  “I look forward to working with our partners, the CBR team, and the broader community to develop and deliver much needed sexual and reproductive health products for women and men around the world.”

About the Population Council

The Population Council confronts critical health and development issues—from stopping the spread of HIV to improving reproductive health and ensuring that young people lead full and productive lives. Through biomedical, social science, and public health research in 50 countries, we work with our partners to deliver solutions that lead to more effective policies, programs, and technologies that improve lives around the world. Established in 1952 and headquartered in New York, the Council is a nongovernmental, nonprofit organization governed by an international board of trustees.

# # #

Media contact

Kevin Short; +1 212 339 0509